MYLK and neoplasm: In addition, we have not elucidated the precise pathway of tumor-derived MAMDC2 entry into CAFs, the molecular mechanism by which MAMDC2 regulates MYLK expression in CAFs, or its biological effects on CAFs—key questions that require further investigation.